151 related articles for article (PubMed ID: 28076824)
1. Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors.
Loughlin WA; Jenkins ID; Karis ND; Healy PC
Eur J Med Chem; 2017 Feb; 127():341-356. PubMed ID: 28076824
[TBL] [Abstract][Full Text] [Related]
2. 2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship study.
Loughlin WA; Jenkins ID; Karis ND; Schweiker SS; Healy PC
Eur J Med Chem; 2016 Mar; 111():1-14. PubMed ID: 26851835
[TBL] [Abstract][Full Text] [Related]
3. Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.
Karis ND; Loughlin WA; Jenkins ID; Healy PC
Bioorg Med Chem; 2009 Jul; 17(13):4724-33. PubMed ID: 19443226
[TBL] [Abstract][Full Text] [Related]
4. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Andersen B; Westergaard N
Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
[TBL] [Abstract][Full Text] [Related]
5. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
[TBL] [Abstract][Full Text] [Related]
6. The glycogen phosphorylase inhibitor 2-(3-benzylamino-2-oxo-1,2-dihydropyridin-1-yl)-N-(3,4-dichlorobenzyl)acetamide.
Popova I; Healy PC; Loughlin WA; Karis ND; Jenkins ID
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1408-10. PubMed ID: 24192198
[TBL] [Abstract][Full Text] [Related]
7. Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.
Zhu P; Bi Y; Xu J; Li Z; Liu J; Zhang L; Ye W; Wu X
Bioorg Med Chem Lett; 2009 Dec; 19(24):6966-9. PubMed ID: 19889536
[TBL] [Abstract][Full Text] [Related]
8. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
Habash M; Taha MO
Bioorg Med Chem; 2011 Aug; 19(16):4746-71. PubMed ID: 21788139
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
[TBL] [Abstract][Full Text] [Related]
10. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
Wang Y; Yan Z; Guo Y; Zhang L
Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
Anderka O; Loenze P; Klabunde T; Dreyer MK; Defossa E; Wendt KU; Schmoll D
Biochemistry; 2008 Apr; 47(16):4683-91. PubMed ID: 18373353
[TBL] [Abstract][Full Text] [Related]
12. Natural flavonoids are potent inhibitors of glycogen phosphorylase.
Jakobs S; Fridrich D; Hofem S; Pahlke G; Eisenbrand G
Mol Nutr Food Res; 2006 Jan; 50(1):52-7. PubMed ID: 16317787
[TBL] [Abstract][Full Text] [Related]
13. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
15. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L
Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507
[TBL] [Abstract][Full Text] [Related]
16. Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
Chen J; Liu J; Zhang L; Wu G; Hua W; Wu X; Sun H
Bioorg Med Chem Lett; 2006 Jun; 16(11):2915-9. PubMed ID: 16546381
[TBL] [Abstract][Full Text] [Related]
17. Glycogen phosphorylase inhibitors: a patent review (2008 - 2012).
Gaboriaud-Kolar N; Skaltsounis AL
Expert Opin Ther Pat; 2013 Aug; 23(8):1017-32. PubMed ID: 23627914
[TBL] [Abstract][Full Text] [Related]
18. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
[TBL] [Abstract][Full Text] [Related]
19. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases.
Wen X; Xia J; Cheng K; Zhang L; Zhang P; Liu J; Zhang L; Ni P; Sun H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5777-82. PubMed ID: 17869102
[TBL] [Abstract][Full Text] [Related]
20. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
